Friday, December 5, 2025
Search

Moderna Stock's Drops 9% As Session Comes To An End On Monday, Underperforms Market

Via News Editorial Team

December 28, 2020

Moderna Stock's Drops 9%  As Session Comes To An End On Monday, Underperforms Market

Shares of Moderna slid 9.45% to $111.73 at 15:58 EST on Monday, following last session's downward trend. NASDAQ Composite is rising 0.92% to $12,922.18, following last session's upward trend, This seems, as yet, a somewhat positive trend trading session today.

Moderna's last close was $123.39, 59.76% below its 52-week high of $178.50.

Moderna's Sales

Moderna's sales growth is 1841.7% for the present quarter and 19117.5% for the next. The company's growth estimates for the ongoing quarter is a negative 13.5% and positive 660% for the next.

Moderna's Revenue

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Volatility

Moderna's last day, last week, and last month's average volatility was a negative 5.63%, a negative 3.21%, and a positive 1.20%, respectively.

Moderna's last day, last week, and last month's high and low average amplitude percentage was 5.69%, 9.93%, and 10.67%, respectively.

Moderna's Stock Yearly Top and Bottom Value

Moderna's stock is valued at $111.73 at 15:58 EST, way below its 52-week high of $178.50 and way above its 52-week low of $17.68.

Moderna's Moving Average

Moderna's value is way under its 50-day moving average of $124.43 and way above its 200-day moving average of $82.50.